Alterola Biotech, Inc.
ABTI
$0.001
-$0.0003-23.08%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -30.65% | 158.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.11% | 141.61% | |||
| Operating Income | 30.11% | -141.61% | |||
| Income Before Tax | -22.07% | -321.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -22.07% | -233.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.67% | -233.39% | |||
| EBIT | 30.11% | -141.61% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | -225.00% | |||
| Normalized Basic EPS | 0.00% | -200.00% | |||
| EPS Diluted | 0.00% | -225.00% | |||
| Normalized Diluted EPS | 0.00% | -200.00% | |||
| Average Basic Shares Outstanding | 2.64% | 4.96% | |||
| Average Diluted Shares Outstanding | 2.64% | 4.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||